University of Mississippi

eGrove
Oxford ICSB

2019 International Conference on the Science
of Botanicals

Apr 8th, 1:00 PM - Mar 8th, 2:30 PM

25 years of DSHEA: Impact on Supply, Conservation and
Sustainability, GACPs and Regulatory Compliance of Botanical
Ingredients
Josef A. Brinkmann
jbrinckmann@tradmed.com

Edward J. Fletcher
Rupa Das
Trish Flaster

Follow this and additional works at: https://egrove.olemiss.edu/icsb

Recommended Citation
Brinkmann, Josef A.; Fletcher, Edward J.; Das, Rupa; and Flaster, Trish, "25 years of DSHEA: Impact on
Supply, Conservation and Sustainability, GACPs and Regulatory Compliance of Botanical Ingredients"
(2019). Oxford ICSB. 6.
https://egrove.olemiss.edu/icsb/2019_ICSB/day1/6

This Panel Discussion is brought to you for free and open access by the National Center for Natural Products
Research at eGrove. It has been accepted for inclusion in Oxford ICSB by an authorized administrator of eGrove.
For more information, please contact egrove@olemiss.edu.

25 years of DSHEA: Impact on Supply, Conservation and Sustainability, GACPs and
Regulatory Compliance of Botanical Ingredients

Presented at the 19th Annual Oxford International Conference on the Science of Botanicals
8 April 2019

Josef A. Brinckmann,1 Edward J. Fletcher,2 Rupa Das,3 Trish Flaster,4
1

Traditional Medicinals, Sebastopol, CA; 2Herbal Ingenuity, Wilkesboro, NC; 3BI

Nutraceuticals, Rancho Dominguez, CA; 4Botanical Liaisons, LLC, Boulder, CO

i

ABSTRACT
Prior to October 1994 in the United States, botanical substances were regulated as
ingredients of drug products, both over-the-counter (OTC) and prescription (Rx), or as
components of food products. Most of the thousands of medicinal plant species in global
commerce were not expressly permitted for use in food products. This fact, coupled with the
reality that the U.S. Food and Drug Administration (FDA) had established panels to review all
old drugs and establish new monographs, led to the eventual re-classification of most botanicals
as non-monograph. Thus, by the early 1990’s many botanicals had no safe harbor, as they were
determined to be unlawful for use as components of both foods and drugs.
The tension caused by these facts is a backdrop, that leads to the U.S. Congress
establishing a new regulatory framework, between food and drug, the Dietary Supplement Health
and Education Act of 1994 (DSHEA). With the passage of DSHEA, most herbs of commerce, if
intended for oral ingestion, became “old dietary ingredients” and could now be marketed with
“nutrient content” or “structure function” claim statements. Botanicals intended for topical
application were not protected by DSHEA however, and, for the most part, transitioned to use in
non-drug cosmetic products, with the exception of a few that remained in the FDA monographs.
Post-DSHEA, the U.S. market for herbal supplements boomed and continues to grow.
This paper examines the impacts of DSHEA, 25-years on, on the ever-increasing market demand
for botanical ingredients, including legal and regulatory issues (state, federal, and international)
affecting production, import, trade and use of botanical supplement ingredients, and the
necessary developments of (a) quality management systems such as good agricultural and
collection practices (GACPs) linked to good manufacturing practices (GMPs); (b) ingredient
quality standards such as pharmacopoeial monographs that can serve as the basis of
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specifications for testing composition, identity, purity, and strength; (c) conservation status
assessments of popular species, as many are obtained through wild-collection; and (d) standards
(national and voluntary) for sustainable agriculture and wild collection practices in order to meet
increasing market demand without detriment to biodiversity.
Key words: Biodiversity; Botanical supplements; Conservation; Quality management,
Sustainable production.
Abbreviations: ABC, American Botanical Council; AHP, American Herbal Pharmacopoeia;
AHPA, American Herbal Products Association; CBD, Convention on Biological Diversity; CFR,
Code of Federal Regulations; CITES, Convention on International Trade in Endangered Species;
CR, Critically Endangered; DSHEA, Dietary Supplement Health and Education Act of 1994; E,
Endangered; EPA, U.S. Environmental Protection Agency; FCC, Food Chemicals Codex; FDA,
U.S. Food and Drug Administration; FD&C Act, Federal Food, Drug, and Cosmetic Act; FEMA,
Flavor and Extract Manufacturers Association; FLO, Fair Trade International; FR, Federal
Register; FSMA, Food Safety Modernization Act; FWF, FairWild Foundation; JECFA, The Joint
Expert Committee on Food Additives; GACP, Good Agricultural and Collection Practices;
GMP, Good Manufacturing Practices; GRAS, Generally Recognized as Safe; GRASE, Generally
Recognized as Safe & Effective; HARPC, Hazard Analysis and Risk-Based Preventive Controls;
IUCN, International Union for Conservation of Nature; LC, Least Concern, MAP, Medicinal and
Aromatic Plants; MPWG, Medicinal Plant Working Group (of USFWS); MPSG, Medicinal
Plant Specialist Group (of IUCN); NOP, National Organic Program; NT, Near Threatened; OTC,
Over-the-counter drug product; R, Rare; UEBT, Union for Ethical BioTrade; UpS, United Plant
Savers; USC, U.S. Congress; USDA, U.S. Department of Agriculture; USFWS, U.S. Fish and
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Wildlife Service; USP-NF, U.S. Pharmacopeia and National Formulary; VSS, Voluntary
Sustainability Standards; VU, Vulnerable; WHO, World Health Organization.
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I.

INTRODUCTION

A. Pre-DSHEA Regulatory Landscape
In the United States (U.S.), prior to the passage of the Dietary Supplement Health and
Education Act of 1994 (DSHEA) (USC 1994), botanicals were regulated as either botanical drug
ingredients (over-the-counter (OTC) or prescription (Rx)), as non-drug cosmetic ingredients, or
as conventional food ingredients. There was no middle ground between drug and food.
A famous case that begged for a middle ground began in 1988, when a shipment of black
currant (Ribes nigrum L.) seed oil from England was seized by U.S. Marshals. The U.S. Food
and Drug Administration (FDA) argued that by merely filling the seed oil into gelatin capsules,
the botanical substance would become an unsafe food additive and therefore an adulterated food,
i.e. the gelatin capsule being the food. In 1991, the U.S. District Court for the Central District of
Illinois ruled in favor the importing company and dismissed the case. In 1992, the FDA appealed
the decision to the United States Court of Appeals for the Seventh Circuit. In January 1993, the
appeals court affirmed the lower court decision, again, in favor of the importing company
(Blumenthal 1994a).
For a botanical to have been permitted for use as a food ingredient, it required FDA
classification as either a (1) Generally Recognized as Safe (GRAS) substance (listed in FDA
regulations, Title 21 Code of Federal Regulations [21 CFR], Parts 182 and 184); or, as a (2) food
additive or color additive (listed in 21 CFR Parts 172, 173 and Parts 73, 74, respectively), and/or
flavoring substance evaluated by the Flavor and Extract Manufacturers Association (FEMA) and
the Joint Expert Committee on Food Additives (JECFA); or, as a (3) prior-sanctioned substance,
approved for specific uses in foods prior to September 6, 1958 (listed in 21 CFR Part 181) (FDA
2018a).
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While many botanical substances had been classified as old drugs, i.e. as active ingredients
of medicinal products sold from the early 19th century through the late 20th century, in the mid1970’s, the FDA established expert review panels for the purposes of assessing the available
evidence of safety and efficacy for all existing OTC drug active ingredients and establishing new
labeling standards monographs. This process included the review of hundreds of “old” botanical
drugs that were still on the pharmacy shelves in the 1970’s. This is an important fact to consider
in the historical context that led to the creation of DSHEA in the 1990’s. From the mid-1970’s
through the mid-1990’s, most botanical substances listed in FDA’s proposed and tentative final
monographs were removed, due to the agency’s inability (at that time) to determine sufficient
levels of evidence to support the claimed therapeutic uses. It is worth noting, however, that
during the same time frame, other national health authorities (notably the German Federal Health
Office (BGA)), were publishing positive therapeutic monographs for many of the same botanical
drugs. Levels of evidence were defined differently in different countries. FDA’s reclassification
of many important botanicals as “non-monograph” created a tension between industry and
government. Suddenly non-monograph botanicals had no safe-harbor for market access, as they
were determined to be unlawful for use as components of both foods and drugs.
In 1992, as a strategy to address the issue, the European-American Phytomedicines Coalition
(EAPC), a group of European and American phytomedicine manufacturers petitioned the FDA to
expand its review of OTC drugs “to include products that have a long and safe history of use as
nonprescription drugs in Western Europe.” To no avail, the EAPC subsequently filed two
citizens' petitions with the FDA, to allow the sale of (1) valerian as an OTC nighttime sleep aid;
and (2) ginger as an OTC antiemetic drug product (Blumenthal 1994, 1995).
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Also in 1992, the American Herbal Products Association (AHPA) listed about 550 botanical
species in their Herbs of Commerce, the majority of which had evidence of acceptable uses in
food products (e.g. species listed in 21CFR, Parts172.5100,182.10 and 182.20), although the
AHPA list also included species that were used only as botanical drugs (Foster 1992). In 1997,
the FDA incorporated the AHPA list into regulation (21 CFR §101.4), requiring that the common
or usual name of ingredients of dietary supplements (algal, botanical, and fungal) shall be
consistent with the names standardized in the 1992 version of Herbs of Commerce (FDA 1997).
The second edition of AHPA’s Herbs of Commerce increased the estimated number of species in
U.S. commerce to 2,048 (AHPA 2000), and, in 2007, the International Union for Conservation of
Nature (IUCN) estimated that about 3,000 medicinal and aromatic plant (MAP) species were in
import-export trade (IUCN 2007). The point being that, of the thousands of herbs of commerce,
most were not expressly listed as permitted for use in conventional food products. And, given the
fact that only 2 new botanical drugs (out of over 600 applications) have been approved by the
FDA in the 25 years since DSHEA, most botanicals must continue to navigate the middle ground
between drug and food, as botanical dietary supplements. Both of the recently approved
botanical drugs are prescription-only medicines with narrow indications for use, (1) an ointment
containing a partially purified extract of green tea (Camellia sinensis (L.) Kuntze) leaf for
treating genital/perianal warts, approved in 2006, and (2) a preparation of dragon’s blood
(Croton lechleri Müll.Arg.) latex for treating HIV-related diarrhea, approved in 2012 (Wu 2017).
After the passage of DSHEA, most oral ingestion herbal medicinal products transitioned to
labeling as per the newly established dietary supplement subset of food regulations. However,
the new regulatory framework provided no safe harbor for topical application botanical
substances. While several of these did remain as Generally Recognized as Safe and Effective
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(GRASE) active ingredients in FDA tentative-final monographs in the Federal Register (FR) or
final monographs in the Code of Federal Regulations (CFR), e.g. Capsicum Oleoresin USP,
Cocoa Butter NF, Colloidal Oatmeal USP, Topical Starch USP, and Witch Hazel USP, most
external application botanical products in the market transitioned to non-drug cosmetic labeling.

B. Post-DSHEA Market Boom
The botanical ingredient sector experienced an initial market boom due to the fact that
DSHEA removed considerable market access barriers and afforded the opportunity to make
claim statements on labeling, including many formerly OTC drug monograph structure function
claim statements. At first, the boom benefited a range of clinically-tested herbal extract products
that already had marketing authorizations as OTC medicines in European countries and in
neighboring Canada. These same herbal medicinal products quickly poured into the U.S. market,
although labeled as dietary supplement products rather than as medicines. At the same time,
scores of lower-cost look-alike products entered the market making it difficult for consumers to
differentiate the good from the bad. It wasn’t unusual in the 1990’s to read market reports of
ginseng (Panax spp.) product retail sales increasing by nearly 250% over previous year (Anon
1994) or St. John’s wort (Hypericum perforatum L.) product sales increasing by over 2,800%
from 1997 to 1998 (Brevoort 1998).
Although the top botanical products of the 1990’s had relatively stable markets established in
Europe, the new rapidly increasing market demand in the U.S. stimulated by the passage of
DSHEA triggered considerable supply chain challenges, in terms of both quality and quantity.
Suppliers of botanical raw materials spent the 1990’s scaling up production to keep up with
spikes in demand, significantly increasing farm acreage and wild collection areas. But, then,
booms do lead to busts, which hit the sector hard by the end of the decade. While the top-selling
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botanical supplements of the 1990’s are still important today, their rankings have dropped and
stabilized as new entries have displaced them. For example, turmeric (Curcuma longa L.)
rhizome supplements are top-sellers today but were unheard of in the 1990’s. Table 1 shows the
top-selling botanical supplement products in the U.S. mass market in 1998 compared with their
rankings in 2017.
Table 1: Top-selling botanical supplements – U.S. Mass Market – 1998 vs. 2017 ranking
Primary ingredient(s) of supplement
1998 ranking
Ginkgo (Ginkgo biloba L.)
1
St. John’s wort (Hypericum perforatum L.)
2
Ginseng (Panax ginseng C.A.Mey. or P. quinquefolius L.)
3
Garlic (Allium sativum L.)
4
Echinacea (Echinacea angustifolia DC., E. pallida (Nutt.) Nutt., or E.
5
purpurea (L.) Moench)
Saw palmetto (Serenoa repens (W.Bartram) Small)
6
Grape seed (Vitis vinifera L.)
7
Kava-kava (Piper methysticum G.Forst.)
8
Evening primrose (Oenothera biennis L., O. lamarckiana Ser.)
9
Echinacea/Goldenseal (Echinacea spp. and Hydrastis canadensis L.)
10
Cranberry (Vaccinium macrocarpon Aiton)
11
Valerian (Valeriana officinalis L.)
12
Source: Data extrapolated from Brevoort (1998) and Smith et al. (2018).

2017 ranking
21
37
25
18
2
14
Not in top-40
Not in top-40
40
Not in top-40
3
16

C. Botanical Supply Chain Challenges
While the botanical ingredients market was booming, feeding the new dietary supplement
finished product sector, the fundamentals to support it were lacking and yet to be developed. At
that time, quality assurance and management systems such as good agricultural and collection
practice (GACP) guidelines and implementable standards for sustainable production, suitable for
cultivated and/or wild-collected botanical crops, were non-existent.
The U.S. Department of Agriculture (USDA) organic regulations, inclusive of a wild-crop
harvesting practice standard, of particular relevance to botanicals, came into force in 2001
(USDA 2000). Guidance on how to comply with the new wild-crop standard, however, was not
published for another decade, in July of 2011 (USDA 2011). In the meantime, in 2006, a
nonprofit organization, the American Herbal Products Association (AHPA) published GACPs
5

for herbal raw materials (relevant to both farmed and wild-collected botanicals), in collaboration
with another nonprofit, the American Herbal Pharmacopoeia (AHP). As members of the AHPA
Botanical Raw Materials Committee, authors of this paper were deeply involved with the
development of the GACP document (AHPA 2006).
Authoritative or official quality standards from which to establish ingredient specifications
for testing and verifying botanical identity, composition, strength and purity, were also lacking.
From the first publication of the Pharmacopoeia of the United States of America in 1820 (USPC
1820) until 1920, around 875 botanical monographs were published in the USP (USPC 2016).
including botanical drug substances and botanical preparations. However, with late nineteenth
century advances in chemistry, the USP began to withdraw many botanical drug monographs. In
the early twentieth century, only 170 botanical monographs remained, and by 1995, there were
fewer than 40 USP monographs for botanicals and their preparations (Schiff et al 2006). In 1995,
two important initiatives commenced, (1) the United States Pharmacopeial Convention (USPC)
adopted a resolution that led to the election of a 5-year term (1995-2000) subcommittee to
explore candidate botanicals for dietary supplement monograph development work; and (2) the
nonprofit organization AHP was established for the express purpose of developing
comprehensive monographs for quality control testing of botanical raw materials and extracts
used in dietary supplement products.
Another considerable challenge for the rapidly growing botanical supplement sector was the
fact that many of the most popular botanical ingredients were procured, for the most part, from
wild harvesting networks in rural and remote areas often through informal, non-documented cash
trade lacking transparency and traceability. It wasn’t until the early 2000’s that the new USDA
organic regulations enabled chain-of-custody and traceability of wild crops, due to the
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documentation and mapping requirements for inspection and certification. Popular high-demand
wild harvested botanicals at that time included (European) bilberry (Vaccinium myrtillus L.) fruit
and leaf, black cohosh (Actaea racemosa L.) rhizome, cascara sagrada (Frangula purshiana
Cooper) bark, (Peruvian) cat’s claw (Uncaria tomentosa (Willd. ex Schult.) DC.) bark,
(European) dog rose (Rosa canina L.) hip, echinacea (Echinacea angustifolia DC.) root,
(Siberian) eleuthero (Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.) root, goldenseal
(Hydrastis canadensis L.) rhizome, licorice (Glycyrrhiza glabra L., G. uralensis Fisch.) root,
saw palmetto (Serenoa repens (W.Bartram) Small) berry, slippery elm (Ulmus rubra Muhl.)
bark, St. John’s wort (Hypericum perforatum L.) flowering tops, and wild yam (Dioscorea
villosa L.) rhizome, among many others.
The conservation status of most medicinal plants had yet to be assessed, and the
development of international standards for sustainable wild collection and ecosystem
management were still a decade away. While the World Health Organization (WHO) 1993
“Guidelines on the Conservation of Medicinal Plants” existed (WHO, IUCN & WWF 1993),
which provided a framework with recommended actions, they had little impact on industry. It
was probably not until 1996 that the industry really sat up and took notice, when the World
Wildlife Fund-US (WWF) suggested that the U.S. Fish & Wildlife Service (USFWS) propose
listing the popular botanical goldenseal onto Appendix II of the Convention on International
Trade in Endangered Species (CITES) (USFWS 1996).
And, it wasn’t until the early 2000’s, that rigorous international standards and
corresponding guidance documents for sustainable wild collection of botanicals were being
developed and test-implemented globally for feasibility, in collaboration with herbal companies
(some American) and nature conservation organizations (e.g. WWF), with the financial and
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technical support of European governmental agencies. This included the (1) German-government
supported “International Standard for the Sustainable Wild-Collection of Medicinal and
Aromatic Plants” (ISSC-MAP) Draft 1 (Leaman 2004), Draft 2 (Leaman & Salvador 2005),
Working Draft (MPSG 2006), and Version 1.0 (2007) (MPSG 2007); and (2) the Swissgovernment supported “FairWild Standard,” Version 1.0 (Meinshausen et al. 2006) and Version
2.0 (FWF 2010), the latter which incorporated the ISSC-MAP as the result of the two initiatives
merging in October 2008 (Brinckmann 2009).

II.

Managing quality and sustainability
When DSHEA came into being, the U.S. botanical ingredients and products sectors, for

the most part, did not yet have the requisite standards and tools developed to cope with, not only
exponential market growth and strains on capacity, but also a series of regulations that would
require development and implementation of standards for quality management and sustainability
of botanical ingredients from the field to post-harvest processing, and on to finished product
manufacturing. This chapter will tie the thread of quality management from implementation
GACPs and sustainable production standards in the field to GMPs in the processing facilities
with application of pharmacopoeial quality standards in the testing laboratories as the basis of
specifications for ensuring the proper composition, identity, purity, and strength of the botanical
ingredient. Table 2 provides a chronology of significant post-DSHEA developments related to
managing the quality and sustainability of botanical supplement ingredients in the U.S.
Table 2: Historical timeline of significant post-DSHEA events impacting quality and sustainability of botanical
supply
Date
1994, Oct. 25
1995, Mar. 9-12

Event
U.S. Congress “Dietary Supplement Health and Education Act of 1994” (DSHEA) becomes
law. The Act afforded legal recognition to USP-NF standards for dietary supplement quality.
U.S. Pharmacopeial Convention (USPC) adopted Resolution No. 12, a resolution that
“encouraged the USP to explore the feasibility and advisability of establishing standards and
developing information concerning dietary supplements.”
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Date
1995

1995
1997, Sept. 18
1997, Dec. 16
1999
2000
2000, Dec. 21
2004, Nov.
2006, Dec.
2007, Jun. 25
2008, Dec. 29
2010, Oct. 29
2011, Jan. 4
2011, Jul. 22
2011, Nov. 2

2012
2015, Sept. 17
2016, Jan. 15
2017, March

Event
Nonprofit organization, the American Herbal Pharmacopoeia (AHP) is established with a
purpose to produce comprehensive monographs that outline the quality control criteria needed
for ensuring the identity, purity, and quality of botanical raw materials.
Nonprofit organization, the United Plant Savers (UpS) is founded with a mission “to protect
native medicinal plants of the United States and Canada and their native habitat while ensuring
an abundant renewable supply of medicinal plants for generations to come.”
Goldenseal (Hydrastis canadensis) enters Appendix II of the Convention on International Trade
in Endangered Species (CITES) as proposed by the U.S. Fish and Wildlife Service (USFWS).
USDA proposes establishment of a national organic program to include wild-crop harvesting.
The Medicinal Plant Working Group (MPWG) was established under the umbrella of the Plant
Conservation Alliance (PCA), facilitated by the USFWS.
Nonprofit UpS publishes At-Risk and To-Watch list of native American botanicals.
USDA National Organic Program (NOP) final rule, which, of particular relevance to sustainable
botanical supply, includes a “Wild-crop Harvesting Practice Standard” (7 CFR § 205.207).
Nonprofit organization, the American Herbal Products Association (AHPA) publishes
“Background on California Proposition 65: Issues related to heavy metals and herbal products.”
AHPA publishes “AHPA-AHP Good Agricultural and Collection Practice for Herbal Raw
Materials,” prepared by members of the AHPA Botanical Raw Materials Committee.
U.S. FDA final rule “Current Good Manufacturing Practice in Manufacturing, Packaging,
Labeling, or Holding Operations for Dietary Supplements (21 CFR Part 111).
USDA Forest Service final rule on “Special Forest Products and Forest Botanical Products.”
United Nations treaty affecting access & trade of medicinal plants adopted: “Nagoya Protocol
on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from
their Utilization to the Convention on Biological Diversity,” and came into force Oct. 12, 2014.
U.S. Congress “FDA Food Safety Modernization Act” becomes law.
USDA NOP issues guidance on organic “Wild Crop Harvesting.”
Three nonprofit organizations, the American Botanical Council (ABC), the AHP, and the
University of Mississippi’s National Center for Natural Products Research (NCNPR) initiated
the “ABC-AHP-NCNPR Botanical Adulterants Program” to educate members of the herbal and
dietary supplement industry about ingredient and product adulteration.
USPC published first edition of the Dietary Supplements Compendium (DSC), which brought
together monographs and general chapters of FCC, NF and USP.
U.S. FDA final rule “Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based
Preventive Controls for Human Food” (21CFR Part 117).
USDA NOP issues guidance on “Natural Resources and Biodiversity Conservation” for organic
operations (farms and wild-collection operations).
AHPA publishes updated “Good Agricultural and Collection Practices and Good
Manufacturing Practices for Botanical Materials.”

A. 1995-2000: AHP and USP begin to develop botanical monographs
Due to the passage of DSHEA, the advisability of developing botanical supplement
monographs was deliberated at the 1995 Quinquennial Meeting of the United States
Pharmacopeial Convention (USPC). The Convention adopted a resolution to encourage USP to
explore the feasibility and advisability of establishing standards and developing information
concerning dietary supplements. A subcommittee on natural products was elected for a five-year
9

term (1995-2000). The subcommittee, with the assistance of an appointed advisory panel, began
the work to select candidate botanicals for monograph and methods development (Schiff et al
2006). Also in 1995, the nonprofit AHP was founded, and, in the meantime, has developed and
published nearly 40 botanical monographs, possibly the most comprehensive compendium
available providing standards for identity, analysis, and quality control.
While the use of official pharmacopoeial standards is mandatory for quality specifications of
botanical drugs, their use is voluntary for botanical dietary supplements in the U.S.
“The Dietary Supplement Health and Education Act of 1994 (DSHEA) amendments to
the Federal Food, Drug, and Cosmetic Act (FD&C Act) named the United States
Pharmacopeia and National Formulary (USP-NF) as official compendia for dietary
supplement ingredient quality standards. At the same time, industry compliance with
USP-NF standards was made voluntary. Nonetheless, the amendments stipulate that if an
herbal dietary supplement that is covered by the specifications of an official compendium
is represented as conforming to the specifications of an official compendium, and fails to
conform to such specifications, it shall be deemed misbranded. Thus, compliance with a
USP monograph becomes mandatory only in cases where the product label specifies that
it contains components with a USP quality designation” (Brinckmann 2011).
One of the co-authors of this paper (JAB) submitted comments on FDA’s draft cGMPs
suggesting that use of authoritative quality standards, such as those published in pharmacopoeial
monographs, should be a required minimum basis for the establishment of botanical supplement
ingredient specifications, in that it could be disingenuous or fraudulent for companies to market
products with claim statements, where the evidence to support the claim is based on the use of a
specified pharmacopoeial quality, if, in fact, the company was using inferior quality grades of
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botanical raw materials. In the preamble of the final rule, while FDA stated that companies may
use validated methods that can be found in official references, such as AOAC International,
USP, and others, the agency rejected the argument that pharmacopoeial quality should be a
minimum requirement for ingredients that are the subject of structure function claim statements
(FDA 2007).
In a critique of the FDA cGMPs, published in Food and Drug Law Journal, representatives
of the USPC stated:
“Unfortunately, these cGMPs establish no minimum requirement for quality. The
manufacturer is entitled to use its best judgment in establishing a standard. Moreover,
although the cGMPs will help ensure that one manufacturer’s product is similar from
batch to batch, the specifications for similar articles can vary widely from manufacturer
to manufacturer. Effectively, the cGMPs call for standards without standardization. A
manufacturer may create essentially private standards for a particular dietary ingredient
or dietary supplement, but the manufacturer need not make these standards public. One
manufacturer’s standards may bear little or no resemblance to the standards created by
other manufacturers for the same ingredient or product. Thus multiple manufacturers may
establish different standards of identity, strength, quality, and purity for articles that are
introduced into commerce under the same name” (Miller et al 2008).
Regardless of the fact that it was not mandatory for manufacturers of supplement products to
base their ingredient quality specifications on pharmacopoeial standards, considerable progress
has been made over the past 25 years. Monographs relevant to specifying the quality of botanical
supplement ingredients have been made available through the American Herbal Pharmacopoeia
(AHP), Food Chemicals Codex (FCC), National Formulary (NF) and United States
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Pharmacopeia (USP). Furthermore, the USPC, since 2012, publishes a separate Dietary
Supplements Compendium (DSC), which provides monographs and general chapters of FCC,
NF and USP along with supplemental information such as color plates and illustrations (USPC
2019). Table 31 provides a list of monographs available for botanical raw materials and extracts
and oils obtained from them.

B. 2000: USDA final rule for NOP (7 CFR Part 205)
In 2000, the USDA NOP final rule was published, which, of particular relevance to
sustainable botanical supply, included the “Wild-crop Harvesting Practice Standard” (7 CFR §
205.207).
Experience has shown that the implementation of sustainability standards may also
contribute to compliance with certain aspects of FDA’s cGMPs, especially where they pertain to
management and control of contamination. For example, the USDA NOP soil fertility and crop
nutrient management practice standard (7 CFR §205.203) requires producers to manage plant
and animal materials to maintain or improve soil organic matter content in a manner that does
not contribute to contamination of crops, soil, or water by plant nutrients, pathogenic organisms,
heavy metals, or residues of prohibited substances. Furthermore, if a botanical supplement
component is certified organic, 7 CFR §205.670(c) requires pre-harvest or post-harvest tissue
test sample collection to be performed by an inspector or certifying agent.
“Sample integrity must be maintained throughout the chain of custody, and residue
testing must be performed in an accredited laboratory. Chemical analysis must be made
in accordance with AOAC methods or other current applicable validated methodology
determining the presence of contaminants in agricultural products” (USDA 2000).

1

Due to its large size, Table 3 is presented under ANNEX I
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C. 2006: AHPA-AHP GACPs
The genesis of the development of GACPs, specifically designed for MAP crops (farmed and
wild), can be traced to an initial 1983 round-table discussion at the 4th International Society for
Horticultural Science (ISHS) Symposium in Angers, France (Máthé & Franz 1996). It would
however be another 20 years before an elaboration of general international GACP guidelines for
medicinal plants would be published by the World Health Organization (WHO 2003a). The
“WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants”
were developed in response to Resolution WHA56.31 from the Fifty-sixth World Health
Assembly on Traditional Medicine which requested the Director-General to provide technical
support for development of methodology to monitor or ensure product quality, efficacy and
safety, preparation of guidelines, and promotion of exchange of information (WHO 2003b). The
WHO GACP guidelines were primarily intended to provide “general” yet globally applicable
technical guidance with the awareness that the GACPs would need to be adjusted according to
each country’s actual situation. One of the main objectives of these general guidelines was to
provide the basis for the formulation of national and/or regional GACP guidelines, speciesspecific GACP monographs, and related standard operating procedures (SOPs).
While many national and international governmental organizations have developed and
implemented national GACPs for MAPs, for example, the China Food and Drug Administration
(CFDA 2002), Japanese Ministry of Health, Labour and Welfare (WHO 2003a), European
Medicines Agency (EMA) (HMPC 2006), and India’s National Medicinal Plants Board (NMPB
2009a, 2009b), the U.S. has not yet. While GACP compliance is mandatory for botanical drugs it
is voluntary for botanical supplements. In their 2004 guidance for industry on botanical drug
products (FDA 2004), the FDA deferred to the EMA GACPs:
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“Starting materials of botanical origin that are used to produce a botanical drug substance
should be evaluated for quality. The use of appropriate starting materials and the drug
substance manufacturer’s ability to control the source depend on appropriate
specifications (tests, analytical procedures, and acceptance criteria). In addition to
establishing specifications, manufacturers can achieve adequate quality control of starting
materials by applying the principles outlined in FDA’s botanical guidance and by
following good agricultural and good collection practice for starting materials of herbal
origin (e.g., European Medicines Evaluation Agency HMPWP/31/99)” (FDA 2004).
However, in the FDA’s revised botanical drug guidance (FDA 2016), the agency deferred to both
the EMA and WHO GACPs:
“To assess quality and therapeutic consistency, it is important to select representative raw
material batches (i.e., raw material from three or more representative cultivation sites or
farms) for the manufacturing of the clinical drug substance for multiple batch Phase 3
studies. The sponsor should establish large growing regions with three or more
cultivation sites or farms whose locations are purposefully selected to be representative of
the regions for each of the botanical raw materials following the principles of Good
Agricultural and Collection Practices (GACP).” [Note: FDA footnotes this statement with
“See the World Health Organization’s “WHO guidelines on good agricultural and
collection practices (GACP) for medicinal plants” and the European Medicines Agency’s
“Guideline on Good Agricultural and Collection Practice (GACP) for Starting Materials
of Herbal Origin”]” (FDA 2016).
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And, while the USPC has, in the past, proposed to develop a new General Chapter section on
GACPs, USP General Chapter <2030> “Supplemental Information for Articles of Botanical
Origin” provides general guidance deferring to the WHO GACP:
“It is recommended that, at a minimum, growers and others involved in the handling and
distribution of botanical products should become familiar with and follow the WHO
Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants”
(USPC 2018a).
Thus, for the U.S. context of quality management of botanical crops, in lieu of official
GACPs from either the FDA or USP, two nonprofit organizations, AHPA and AHP collaborated
in the production of the “AHPA-AHP Good Agricultural and Collection Practice for Herbal Raw
Materials,” initiated under the auspices of the AHPA Botanical Raw Materials Committee
(AHPA 2006). While it has no legal standing in the U.S., AHPA states that its GACP has
relevance to herbal raw materials used in all herbal products, including cosmetics, dietary
supplements, drugs, and foods. However, it should also be noted that the Canadian government
officially recognized the AHPA-AHP GACP in their “Quality of Natural Health Products
Guide” as acceptable for botanical medicinal ingredients of licensed natural health products in
Canada (NNHPD 2015).

D. 2007: U.S. FDA final rule cGMPs (21 CFR Part 111)
FDA’s 2007 final rule on cGMP in manufacturing, packaging, labeling, or holding operations
for dietary supplements (21 CFR Part 111) required the establishment of quality specifications
with scientifically valid methods for ensuring the composition, identity, purity and strength of
dietary supplement components, as well as the establishment of limits on types of contamination
that may adulterate or may lead to adulteration (FDA 2007). Experience of some companies has
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shown that compliance with the cGMP can be accomplished by implementing other standards
earlier in the botanical supply chain. For example, GACP compliance generally requires written
agreements between producers and buyers of botanicals with regard to quality such as content of
active principle, macroscopical and olfactory properties, limit values for microbial
contamination, chemical residues and heavy metals, and that specifications should be based on
recognized national pharmacopoeial monographs (HMPC 2006). And, basing one’s quality
specification on quality standards monographs such as those of the USP ensure that scientifically
valid methods and limits will be established for determining composition, identity, purity, and
strength.
Subsequently, in 2011, also impacting the production and trade of botanical dietary
supplement ingredients, Congress enacted the Food Safety Modernization Act (FSMA)
“in response to dramatic changes in the global food system and in our understanding of
foodborne illness and its consequences, including the realization that preventable
foodborne illness is both a significant public health problem and a threat to the economic
well-being of the food system. FSMA is transforming the nation’s food safety system by
shifting the focus from responding to foodborne illness to preventing it” (FDA 2018b).
As part of the FSMA, Congress has enacted several rules:
Preventive Controls for Human Food
Foreign Supplier Verification Program for Importers of Food for Human and Animals
Sanitary Transportation of Human and Animal Food
Mitigation Strategies to Protect Food against Intentional Adulteration
Accredited Third Party Certification
Preventive Controls for Food for Animals
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Standards for Produce Safety
While these rules are now final, all corresponding guidance documents are not yet finalized.

III.

Control of adulterants and contaminants
This section discusses the problems and solutions concerning adulteration of botanical

ingredients, whether intentional (economic) or unintentional (look-alike species growing in
proximity to target species). Additionally unavoidable contamination of botanical ingredients has
become one of the most disruptive quality problems negatively impacting trade and quality of
products. Our planet is not getting cleaner. Anthropogenic pollution and related contamination to
the natural environment is now global and pervasive. Types of pollution affecting botanical
crops, whether farmed or wild-collected, include heavy metals contamination from industrial
pollution, nonpoint source pesticide pollution from conventional agriculture operations
negatively impacting certified organic crops and wild crops, pharmaceutical drugs in irrigation
water, plastic pollution, polycyclic aromatic hydrocarbons (PAHs), and radioactive residues.
i.

Economic adulteration
In 2011, three nonprofit organizations, the ABC, the AHP, and the University of

Mississippi’s National Center for Natural Products Research (NCNPR) initiated the “ABC-AHPNCNPR Botanical Adulterants Program” to educate members of the herbal and dietary
supplement industry about ingredient and product adulteration.

To date, seventeen

comprehensive Botanical Adulterant Bulletins have been published and seven laboratory
guidance documents (Table 4), among other materials useful for the industry
Table 4: Botanical Adulterants Program bulletins and laboratory guidance documents list
Date
Title
2015, January
Skullcap Adulteration Laboratory Guidance Document
2015, August
Bilberry Fruit Extract Laboratory Guidance Document
2015, November
Black Cohosh Adulteration Laboratory Guidance Document
2016, April
Adulteration of Bilberry (Vaccinium myrtillus) Extracts
2016, April
Adulteration of Grape Seed Extract (Vitis vinifera)
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Date
Title
2016, April
Adulteration of Skullcap (Scutellaria lateriflora)
2016, June
Adulteration of Black Cohosh (Actaea racemosa)
2016, June
Adulteration of Hydrastis canadensis root and rhizome
2016, August
Adulteration of Arnica (Arnica montana)
2017, January
St. John's Wort (Hypericum perforatum) Adulteration
2017. March
Adulteration of Grapefruit Seed Extract (Citrus paradisi)
2017, May
Grapefruit Seed Extract Laboratory Guidance Document
2017. August
Tea Tree (Melaleuca alternifolia and M. linariifolia) Oil
2017, October
Adulteration of Rhodiola (Rhodiola rosea) Rhizome, Root, and Extracts
2017, December
Adulteration of Cranberry (Vaccinium macrocarpon)
2018, January
Adulteration of Ginkgo biloba Leaf Extract
2018, April
Pomegranate Products Laboratory Guidance Document
2018, May
Turmeric (Curcuma longa) Root and Rhizome, and Root and Rhizome Extracts
2018, June
Boswellia serrata Adulteration
2018, September
Adulteration of Maca (Lepidium meyenii)
2018, September
Tea Tree Oil Laboratory Guidance Document
2018, October
Adulteration of Saw Palmetto (Serenoa repens)
2018, November
Cranberry Products Laboratory Guidance Document
2019, January
Adulteration of Ashwagandha (Withania somnifera) Roots, and Extracts
2019, February
Grape Seed Extract Laboratory Guidance Document
SOURCE: American Botanical Council: http://cms.herbalgram.org/BAP/

ii.

Heavy metal pollutants in the environment
Medicinal plant crops can be contaminated by absorbing heavy metals from soil, water and

air, i.e. from industrial emissions, mining, smelting, landfills, conventional agriculture (fertilizers
and pesticides; polluted water used for irrigation, sewage sludge), transportation (traffic-induced
contaminated atmosphere), rainfall, and atmospheric dust:
Air: Aerial plant parts accumulate heavy metals by uptake of airborne pollution relative
to proximity to industrial zones and traffic (Serbula et al. 2013).
Soil: “Absorption of heavy metal in medicinal plants is governed by soil characteristics
such as pH, salinity, conductivity and organic matter content” (Rădulescu et al. 2013).
Water: “Toxic elements from wastewater may contaminate agricultural soils, water
supplies and environment… Elevated levels of heavy metals in plants are reported from
the areas having long-term uses of treated or untreated wastewater” (Shaban et al. 2016).
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While the United States Pharmacopoeia (USP) prescribes general limits for elemental
impurities in general chapter 561 ARTICLES OF BOTANICAL ORIGIN (USPC 2018b) [see
Table 5], the State of California enacted its own limits through implementation of the Safe
Drinking Water and Toxic Enforcement Act of 1986, more commonly known as California
Proposition 65.
Table 5: USP General Chapter 561 Articles of Botanical Origin - Limits of Elemental Impurities
Element
Arsenic (inorganic)
Cadmium
Lead
Mercury (total)
Methylmercury (as Hg)

Limit (µg/g)
2
0.5
5
1
0.2

The California Proposition 65 limits for heavy metals continue to impact the botanical
dietary supplement trade, from increased testing for selection of California-compliant lots, to
product brands lowering their daily serving size instructions on labeling in order to comply. That
is, because the limits are not based on content but on daily ingestion levels. For example, the
California maximum allowable daily level (MADL) for lead content in an herbal dietary
supplement product is not-more-than 0.5 µg per day. Depending on the recommended daily
serving size for a product, the USP limit of 5 µg per gram (in botanical material) may, or may
not, prove to be compliant in California. In 2004, the American Herbal Products Association
(AHPA) published its “Background on California Proposition 65: Issues related to heavy metals
and herbal products,” (McGuffin & Norris 2004), which was revised in 2008, and in 2010, and
again in 2017, retitled as “Guidance on California Proposition 65 and Herbal Products” (AHPA
2017). AHPA’s document provides guidance for industry on regulatory and liability implications
of Proposition 65 for constituents that may be present in herbal products sold in California.
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iii.

Nonpoint source pesticide contamination
In the decades since the passage of DSHEA, pesticide drift from conventional agriculture

sites has become ubiquitous in the natural world. Residues can now be detected the world over,
in the air, ice, snow, soil and water, and on crops grown without the intentional use of pesticides.
Residues of “legacy” (e.g. DDT) and “current use pesticides” (CUPs) are now detected in
Arctic ice caps (evidence of long range atmospheric transport).
In rural and remote areas, there is widespread contamination of wildflowers and beecollected pollen with agricultural pesticides.
Nonpoint source pesticide detection is an increasing problem even with certified
organically grown and/or wild-collected botanicals, where pesticides have not been
applied.
As per FDA’s 21 CFR Part 111 cGMPs for dietary supplements, specifications are required
to ensure that a dietary supplement derived from a botanical source does not contain
contaminants such as an unlawful pesticide. Pesticide tolerances, however, are established by the
Environmental Protection Agency (EPA) on a crop-specific and/or crop-group basis. While FDA
enforces the EPA limits that were established mainly for food crops, tolerances have been
established for only a relatively small number of botanical crops such as certain aromatic or
culinary herbs that are grown in the U.S. on a large scale, e.g., spearmint (Mentha spicata) and
hops (Humulus lupulus). EPA tolerances have not been established for thousands of other
botanicals in commerce. Thus, when de minimis levels of pesticide residues are found at above
the limit of quantitation (LoQ), even on wild-collected botanicals or on certified organically
grown botanicals, where no pesticides were intentionally applied, there is a risk of FDA
detention or import refusal at the port of entry.
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Although USP General Chapter 561 Articles of Botanical Origin provides reasonable limits
for pesticide residues, in the U.S. the USP limits are applicable only to botanical drugs and not to
botanical dietary supplements. That is because dietary supplements are regulated as a subset of
foods. EPA establishes limits for food crops while USP has the authority to establish limits for
botanical drug crops.
In 2016, a stimuli article titled “Need for Clear Regulation of Pesticide Residue Limits for
Articles of Botanical Origin,” was published in the Pharmacopeial Forum for public comment
(USP Botanical Dietary Supplements and Herbal Medicines Expert Committee 2016). This was
followed-up with a USP roundtable on pesticide residues in botanical dietary supplements with
participants from governmental agencies, trade associations, and industry.

IV.

Conservation and Sustainability
This chapter looks at impacts of international conventions such as the Convention on

Biological Diversity (CBD) and the Convention on International Trade in Endangered Species
(CITES) on botanical ingredient production and import trade, as well as conservation status
assessments of botanical species carried out by non-governmental organizations such as IUCN
Red List assessments, and the emergence of voluntary standards for demonstrating economic,
environmental and social sustainability in the botanical supply chain.
By the start of the 21st century, awareness grew in the global botanical trade that conserving
biodiversity and improving rural economies appeared to be linked to access to traditional
harvesting areas, sustainable production, trade and use of ever-increasing quantities of botanicals
needed for the natural cosmetic, dietary supplement, botanical drug, and functional food sectors.
This was evidenced by the fact that numerous sustainability standards (both national and private
voluntary) as well as GACP standards designed for MAP crop production were being developed
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through multi-stakeholder processes and implemented with funding support from governmental
agencies (e.g. German Federal Agency for Nature Conservation (BfN)), intergovernmental
organizations (e.g. agencies of the United Nations), and non-governmental organizations (e.g.
WWF).
“Implementation of voluntary sustainability standards (VSS) that include economic,
environmental and social criteria and indicators is an emerging market-based approach to
biodiversity conservation, sustainable harvesting and commercial use of MAPs, and to
demonstrate compliance with international agreements. While such standards are
voluntary, in that compliance is not required by governmental regulations, independent
third-party inspection and certification organisations determine if companies are
operating in compliance with the standard” (Brinckmann 2017; Komives & Jackson
2014).
From 2010 to 2014, international botanical ingredient and finished product companies also
needed to learn the (new) ropes for compliance with a United Nations multilateral treaty, adopted
in 2010 for enforcement by 2014, the “Nagoya Protocol on Access to Genetic Resources and the
Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on
Biological Diversity” (Secretariat of the Convention on Biological Diversity 2011). Some of the
aforementioned voluntary sustainability standards provide ways for companies to demonstrate
compliance with the access and benefit sharing (ABS) requirements of the protocol, for example,
the Ethical BioTrade Standard, developed by the Union for Ethical BioTrade (UEBT), and the
FairWild Standard (FWS), developed by the FairWild Foundation. Criterion 4.2 of the FWS
requires that agreements made with local communities and/or indigenous peoples are executed in
compliance with relevant international and national laws and ABS regulations including
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protection of traditional knowledge (FWF 2010). Written and mutually accepted fair and
equitable agreements on use of medicinal plants and associated traditional knowledge must be in
place to maintain FairWild certification (FWF 2013). Section 3 of the Ethical BioTrade Standard
“Fair and Equitable Sharing of Benefits derived from the Use of Biodiversity” includes
comparable requirements (UEBT 2012).
Table 6 provides a listing of selected botanicals with information on their conservation status,
for example if the species is listed in the CITES appendixes, or has been assessed according to
the IUCN Red List criteria or the UpS ranking tool. Species prioritized in the AHPA tonnage
survey are also included in the table if the species has been assessed according to UpS, IUCN or
CITES.
Table 6: Conservation status of selected botanicals used in botanical supplement products
Botanical name
CITES
IUCN Red List
CR, Aquilaria crassna; CR, A.
Agarwood (Aquilaria spp.)
II
malaccensis; VU, A. sinensis
American ginseng (Panax quinquefolius L.)
II
Not assessed
Asian ginseng (Panax ginseng C.A.Mey.) from Russia
II
Not assessed
Arnica (Arnica spp.)
LC, Arnica montana
Bethroot (Trillium erectum L.)
Not assessed
Bletilla (Bletilla striata (Thunb.) Rchb.f.)
II
Not assessed
Bloodroot (Sanguinaria canadensis L.)
Not assessed
Black cohosh (Actaea racemosa L.)
Not assessed
Blue cohosh (Caulophyllum thalictroides (L.) Michx.)
Not assessed
Brazilian rosewood (Aniba rosaeodora Ducke)
II
EN
Candelilla (Euphorbia antisyphilitica Zucc.)
II
No assessed
Cape aloe (Aloe ferox Mill.)
II
Not assessed
Cascara sagrada (Frangula purshiana Cooper)
LC
Chun lan (Cymbidium goeringii (Rchb.f.) Rchb.f.)
II
Not assessed
Common pleione (Pleione yunnanensis (Rolfe) Rolfe)
II
Not assessed
Costus (Saussurea costus (Falc.) Lipsch.)
I
CR
CR, D. huoshanense; CR, D.
Dendrobium (Dendrobium spp.)
II
officinale;
Desert broomrape (Cistanche deserticola Y.C.Ma)
II
Not assessed
Echinacea (Echinacea spp.)
Not assessed
Elephant tree (Bursera microphylla A.Gray)
Not assessed
Eyebright (Euphrasia spp.)
Not assessed
Fragrant rosewood (Dalbergia odorifera T.C.Chen)
II
VU
False unicorn (Chamaelirium luteum (L.) A.Gray)
Not assessed
Gastrodia (Gastrodia elata Blume)
II
VU
Gentian (Gentiana spp.)
CR, G. kurroo
Goldenseal (Hydrastis canadensis L.)
II
VU
Goldthread (Coptis spp.)
EN, C. teeta
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UpS

ATR
TW
ATR
ATR
ATR
ATR

TW

ATR
TW
ATR
ATR
TW
ATR
TW

Botanical name
Guaiacum (Guaiacum spp.)
Hoodia (Hoodia gordonii (Masson) Sweet ex Decne.)
Indian rosewood (Dalbergia sissoo DC.)
Jatamansi (Nardostachys grandiflora DC.)
Jivakah (Malaxis acuminata D.Don)
Lady’s slipper orchid (Cypripedium spp.)
Lobelia (Lobelia spp.)
Lomatium (Lomatium dissectum (Nutt.) Mathias &
Constance)
Oregon grape (Mahonia aquifolium (Pursh) Nutt., M.
nervosa (Pursh) Nutt., M. repens (Lindl.) G. Don))
Osha (Ligusticum porteri J.M.Coult. & Rose, L. spp.)
Partridge berry (Mitchella repens L.)
Perry’s aloe (Aloe perryi Baker)
Picrorhiza (Picrorhiza kurrooa Royle)
Pleurisy (Asclepias tuberosa L.)
Pygeum (Prunus africana (Hook.f.) Kalkman)
Red saunders (Pterocarpus santalinus L.f.)
Riddhi (Habenaria intermedia D.Don)
Sandalwood (Santalum spp.)
Scythian lamb (Cibotium barometz (L.) J.Sm.)
Skullcap (Scutellaria lateriflora L.)
Slippery elm (Ulmus rubra Muhl.)
Sundew (Drosera spp.)
True unicorn (Aletris farinosa L.)
Venus’ fly trap (Dionaea muscipula J.Ellis)
Wild cherry (Prunus serotine Ehrh.)
Wild indigo (Baptisia tinctoria (L.) Vent.)
Wild yam (Dioscorea villosa L., D. spp.)
Witch hazel (Hamamelis virginiana L.)
Yerba mansa (Anemopsis californica (Nutt.) Hook. &
Arn.)

CITES
II
II
II
II
II
II

II
II
II
II
II
II

IUCN Red List
EN, G. officinale; NT, G. sanctum
Not assessed
Not assessed
CR
Not assessed
LC, C. acaule; LC, C. parviflorum
LC, L. cardinalis; LC, L. siphilitica

UpS

ATR
TW

Not assessed

ATR

Not assessed

TW

Not assessed
Not assessed
NT
Not assessed
Not assessed
VU
NT
Not assessed
VU, S. album
Not assessed
LC
LC
Not assessed
Not assessed
VU
LC
Not assessed
Not assessed
LC

ATR
TW

Not assessed

TW

TW

ATR

ATR
ATR
ATR
ATR
TW
ATR

Legend:
CITES Appendices: Appendix I: lists species that are the most endangered; threatened with extinction. CITES prohibits
international trade in specimens of these species except when the purpose of the import is not commercial, for instance for
scientific research. Appendix II: lists species that are not necessarily now threatened with extinction but that may become so
unless trade is closely controlled. It also includes so-called "look-alike species", i.e. species whose specimens in trade look like
those of species listed for conservation reasons. Appendix III: is a list of species included at the request of a Party that already
regulates trade in the species and that needs the cooperation of other countries to prevent unsustainable or illegal exploitation.
IUCN Categories: CR, critically endangered; DD, data deficient; EN, endangered; LC, least concern; NT, near threatened; VU,
vulnerable.
UpS Ranking: ATR, at-risk; TW, to watch.

A. AHPA tonnage survey
The American Herbal Products Association (AHPA) initiated and has conducted “Tonnage
Surveys” since 1999 for the purpose of quantifying the annual harvests of specific North
American botanicals in commerce. AHPA's Tonnage Survey is considered "a vital index of
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native U.S. botanical consumption," according to the Fish and Wildlife Service of the U.S.
Department of the Interior. According to AHPA:
“Harvest information is a more powerful tool when harvest amounts are tabulated to
include combined total usage. By working together, AHPA and the herbal products
industry generate valuable information that helps ensure sustainable growth and stability.
Participation in this survey also demonstrates the industry's commitment to sustainable
harvests” (AHPA 2019).
The first of these surveys addressed only the plant goldenseal (Hydrastis canadensis) and
solicited information about both wild and cultivated harvests for 1998, as well as certain harvest
and cultivation practices. The second survey extended this attention on goldenseal for the 1999
harvest year and also compiled information for the years 1997–1999 for a number of other
plants. The 2000–2001 survey identified all of the plants from these earlier efforts and a number
of additional species. These surveys have continued to evolve by adding new species, more
cultivation oriented, fresh and dried material numbers and other information based on the need of
new data for today’s market. Figure 1 provides a chart illustrating the annual harvested quantities
of four high-volume American botanicals from 1999 through 2010.
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Fig. 1 Annual harvested quantities (dry weight basis) of four high-volume botanicals, 1999-2010, excerpted with permission
from the “Tonnage Surveys of Select North American Wild-Harvested Plants, 2006–2010” (AHPA 2012).

According to AHPA, with regard to its 14 years of harvest data for goldenseal:
“Annual variations in harvest quantities for certain of these commodities are consistent with
market factors over the past several years. This review of data over the fourteen-year period
reveals that patterns in market demand are reflected in annual variations of harvests of both
wild and cultivated sources of these botanical commodities. Several species for which there
are large market demands are cultivated to a sufficient degree so that some meaningful
portion of the total usage is provided by farmers rather than by harvesters of wild plants. The
most recent surveys affirm that this continues to be the case for the goldenseal market…
“However, market demand, not plant availability, seems to be the primary driver of total
harvest quantities. As has been noted in other publications, information about the population
dynamics of many of these species in their native habitats is not well understood” (AHPA
2012).

The latest survey (with submission deadline of 26 April 2019), continues to focus on selected
North American botanicals that are produced in part from wild-harvested populations, but has
been expanded to track 51 herbal commodities representing 44 species, including American
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ginseng, black cohosh, cascara sagrada, Echinacea spp., saw palmetto, slippery elm, and witch
hazel (AHPA 2019).
Data from the AHPA tonnage surveys are the foundational information needed to both track and
assess the sustainability of harvests of North American species in trade within the herbal dietary
supplement and herbal medicine industries. It may still require a collaborative effort between
industry, regulatory and nature conservation organizations to objectively and impartially study the
data thoroughly enough to better understand the impact on native species relative to each species’ life
cycle, while considering other impacts such as human expansion and habitat depletion.

B. Medicinal Plant Working Group
Facilitated by the USFWS, the Medicinal Plant Working Group (MPWG) formed in 1999:
“Recognizing that commercial demands may pose threats to native plants in the United States,
representatives from industry, government, academia, tribes, and environmental organizations
joined together to form the Medicinal Plant Working Group (PCA-MPWG) under the umbrella
of the Plant Conservation Alliance (PCA)” (Lyke 2000). The primary focus of the MPWG has
been to facilitate action in cases where the conservation status of a native medicinal plant is of
concern.

C. UpS ranking tool
While UpS launched their medicinal plant species “At Risk” and “To Watch” lists in 2000, it
was initially informed by input from UpS-member herbalists, ecologists, growers, and buyers. As
the botanical industry continued to grow rapidly, UpS realized that a more transparent
methodology was needed. As the result of a multi-year, multi-stakeholder process, in 2014, UpS
launched what it called a “Ranking Tool Created for Medicinal Plants.” The tool can be used to
quantify and compare vulnerability to overharvest for wild collected medicinal plants, scoring

27

species “according to their life history, the effects of harvest, their abundance and range, habitat,
and demand” (Castle et al. 2014).

D. USDA NOP biodiversity conservation guidance
The general natural resources and biodiversity conservation requirement of the USDA
organic regulations (7 CFR §205.200) requires producers (both farms and wild collection
operations) to “maintain or improve the natural resources of the operation, including soil and
water quality.” And the wild-crop harvesting practice standard (7 CFR §205.207) states that a
“wild crop must be harvested in a manner that ensures that such harvesting or gathering will not
be destructive to the environment and will sustain the growth and production of the wild crop”
(USDA 2000). In 2011, USDA published guidance aiming to clarify the ways in which certified
operations could demonstrate compliance with the standard (USDA 2011). Then, 16 years after
the organic regulations came into force, guidance was finally published on the biodiversity
conservation requirements of organic operations (USDA 2016a). In response to public
comments, USDA stated:
“There are many ways for operations to meet the requirements of § 205.200… Wild
harvest operations may voluntarily elect to follow the FairWild Foundation (FWF)
standards in order to meet the NOP requirements for biodiversity conservation; however
the change was not made to the final guidance” (USDA 2016b).

E. Emergence of voluntary sustainability standards
The end of the 20th century saw the emergence of voluntary sustainability standards (VSS)
relevant to the production and trade of medicinal and aromatic plants according to principles of
economic, environmental, and social sustainability. For example, Fair Trade International (FLO)
was founded in 1997 in Bonn, Germany, and soon afterwards developed fair trade standards for
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herbs, herbal teas, and spices. In 2000, the USDA National Organic Program (NOP) standards
were published. In the first two decades of the 21st century, there has been a proliferation of VSS,
with several hundreds of botanical species being traded globally with one or more certifications.
Table 7 provides a list of selected VSS that are being applied to botanical crops. Implementation
of VSS by botanical producers can, not only fill in some of the gaps in GACP guidelines and
organic agriculture regulations, respectively, but also provide producers with the value-addition
of certifications that demonstrate compliance with credible sustainability standards, that can
strengthen their economic viability and market position (Brinckmann 2016).
Table 7: Selected voluntary sustainability standards applicable to botanical crops
Name of standard
Agricultural Production Standard
Biodynamic® Farm Standard
EcoSocial Fair
Ethical BioTrade Standard

Owner of the standard
Fair Trade USA (FTUSA)
DEMETER Association Inc.
Instituto Biodinâmico de
Desenvolvimento Rural (IBD)
Union for Ethical BioTrade
(UEBT)

Economic
sustainability

Environmental
sustainability

Social
sustainability

✔

✔
✔

✔

✔

✔

✔

✔

✔

✔

✔

✔

✔

✔

Fair Choice Social and Fair Trade
CONTROL UNION (CU)
✔
Standard
Fair For Life Standard
ECOCERT SA
✔
Fairtrade Standard for Herbs, Herbal
Fairtrade Labelling Organizations
Teas & Spices for Small Producer
✔
International, e.V. (FLO)
Organizations and traders
Fairtrade Standard for Herbs and
Fairtrade Labelling Organizations
Herbal Teas for Hired Labour and
✔
International, e.V. (FLO)
Traders
FairTSA Consolidated standards for
the production of agricultural
Fair Trade Sustainability Alliance
products, processed foods, wild
✔
(FairTSA)
collected plants, handicrafts and
personal-care products
FairWild Standard
FairWild Foundation (FWF)
✔
National Standard for Organic
United States Department of
Production
Agriculture (USDA)
Non-GMO Project Standard
Non-GMO Project
Regenerative Organic Certification
Regenerative Organic Alliance
✔
Standard
Sustainable Agriculture Standard
Rainforest Alliance and UTZ
UEBT-UTZ Sustainable Herbal Tea
UEBT and UTZ
✔
Standards
SOURCE: Table created by J.A. Brinckmann for the AHPA Sustainability Sub-committee.
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✔
✔

✔

✔

✔

✔

✔
✔
✔

✔

✔
✔

✔

V.

Conclusion and Recommendations for the future
This paper shows that, twenty-five years since DSHEA, in response to strains caused by a

continually growing market demand for botanical ingredients and products in the United States, a
considerable range of useful standards, guidance manuals, and tools have been developed by
educational organizations (e.g. ABC-AHP-NCNPR), governmental organizations (e.g. FDA,
USDA-NOP), medicinal plant conservation organizations (e.g. IUCN-MPSG, PCA-MPWG,
UpS), quality standards setting organizations (e.g. AHP, USP), sustainability standards setting
organizations (e.g. FLO, FWF, UEBT), and trade associations (e.g. AHPA). While compliance
with FDA regulations governing the manufacture and marketing of herbal dietary supplement
products is mandatory, the use of pharmacopoeial quality standards, GACP standards, and
sustainability standards (all of which support regulatory compliance), is voluntary.
The way that botanical ingredients and products are regulated and marketed in the United
States, for the most part, remains unique and possibly an anomaly in the world, certainly by
comparison to the frameworks of our neighbors and trading partners, such as Canada, Mexico,
the European Union, Australia, Japan, and China. In the aforementioned countries, the same
types of ingredients are generally viewed today as active ingredients for use in licensed, listed, or
registered medicinal products that require pre-marketing authorization. This means that
implementation of suitable GACPs is expected for quality assurance of active ingredients and
use of pharmacopoeial monographs, to serve as the basis for quality specifications, is mandated.
In the United States, GACP implementation and compliance with pharmacopoeial quality
standards is mandatory only for botanical drugs but voluntary for botanical dietary supplements.
This difference leaves it up to the individual company whether, or not, they will make such
commitments to quality that will increase the price of their finished products. It is difficult for
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the consumer in the United States to understand and sort out quality differences between
similarly packaged dietary supplement products (and just about every company claims that they
have the highest quality!).
Commitments to nature conservation, sustainable production and trade is a different
matter and perhaps easier for American companies to communicate. For example, in the
European Union, registered herbal medicinal products are not permitted to carry any certification
logos on the retail packages. That is because of EU medicines policy stating that the conservation
and sustainability status of medicinal ingredients and products have nothing to do with
pharmaceutical quality or safety and efficacy of the medicine. That is an unfortunate policy (for
European consumers concerned with ethical trade and sustainability). However, in the United
States, it is not unusual to find herbal dietary supplement products with multiple credible
certification marks on the labeling, demonstrating to the consumer that the product and its
ingredients conform to a range of environmental, economic, and social sustainability standards.
Regardless of market trends and consumer preferences, companies intrinsically
concerned with reproducible quality, safety and efficacy of their botanical products may need to
engage more deeply in the ecological-economic viability of the rural and remote communities
where so many medicinal plants are produced. With mass migration of youth to urban areas,
happening at a scale never before seen in the world, labor is rapidly disappearing in rural farming
and wild-collection regions. Non-sustainable rural livelihoods can lead to land-use changes, loss
of ecosystem stewardship and biodiversity. The rapid loss of biodiversity in recent decades, not
only impacts access to and quality of wild botanicals, but is reportedly an existential threat
(IPBES 2019). There may be a correlation between sustainable resource management and
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equitable trade, with a companies’ ability to procure increasing quantities of botanicals of a
specified and consistent quality.

VI.
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ANNEX I: Table 3: Botanical, algal, fungal quality standards monographs available
from AHP, FCC, NF, USP
Table 3: Botanical, algal, fungal quality standards monographs available from AHP, FCC, NF, and USP
Monograph
AHP
FCC
NF
Acacia (Gum Arabic)
X
X
Acacia Syrup
X
Agar
X
X
Aloe (Dried Latex)
Aloe Vera Leaf, Leaf Juice & Inner Leaf Juice
X
Ambrette Seed Oil
X
American Ginseng Root
X
American Ginseng Root Dry Extract
Amla Fruit
X
Amyris Oil, West Indian Type
X
Andrographis (Leaf and Stem)
Andrographis Dry Extract
Angelica Root Oil
X
Angelica Seed Oil
X
Anise Oil
X
X
Annatto Extracts
X
ARA from Fungal (Mortierella alpina) Oil
X
Arabinogalactan
X
Astaxanthin Esters (from Haematococcus pluvialis)
X
Ashwagandha Root
X
Ashwagandha Root Dry Extract
Asian Ginseng Root
Asian Ginseng Root Dry Extract
Astragalus Root
X
Astragalus Root Dry Extract
Aztec Marigold Zeaxanthin Extract
Bacopa (Leaf and Stem)
Bacopa Dry Extract
Balsam Peru Oil, Cold-pressed
X
Banaba Leaf
Banaba Leaf Dry Extract
Basil Oil, Comoros Type
X
Basil Oil, European Type
X
Bay Oil
X
Belleric Myrobalan Fruit
X
Bergamot Oil, Cold-pressed
X
Bilberry Fruit
X
Bilberry Fruit Dry Extract
Birch Tar Oil, Rectified
X
Black Cohosh (Rhizome)
X
Black Cohosh Dry Extract
Black Cohosh Fluidextract
Black Haw Bark
X
Black Pepper (Fruit)
Black Pepper Dry Extract
Black Pepper Oil
X
Blue Cohosh Root / Rhizome
X
Bois de Rose Oil
X
Borage Seed Oil
Boswellia serrata (Oleogum Resin)
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USP

X

X
X

X
X

X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X

X
X

Monograph
Boswellia serrata Extract
Cananga Oil
Candelilla Wax
Cannabis Inflorescence
Capsicum (Ripe Fruit)
Capsicum Oleoresin
Capsicum Tincture
Caraway Fruit
Caraway Oil
Cardamom Seed
Cardamom Oil
Cardamom Tincture, Compound
Carnauba Wax
Carrageenan
Carrot Seed Oil
Casanthranol
Cascara Fluidextract, Aromatic
Cascara Sagrada (Aged Bark)
Cascara Sagrada Dry Extract
Cascara Sagrada Fluidextract
Cascarilla Oil
Cassia Oil
Castor Oil
Castor Oil, Aromatic
Castor Oil Emulsion
Cat’s Claw (Stem Inner Bark)
Cat’s Claw Dry Extract
Cedar Leaf Oil
Celery Seed Oil
Centella asiatica (Aerial Parts)
Centella asiatica Dry Extract
Centella asiatica Triterpenes
Chamomile (Flower Heads)
Chamomile Oil, English Type
Chamomile Oil, German Type
Chaste Tree Fruit
Chaste Tree Fruit Dry Extract
Chebulic Myrobalan Fruit
Cherry Juice
Cherry Syrup
Chia Seed Oil
Chinese Salvia (Root and Rhizome)
Chocolate
Chocolate Syrup
Cinnamomum cassia Twig
Cinnamon Bark Oil, Ceylon Type
Cinnamon Leaf Oil
Clary Oil
Clove Flower Bud Oil
Clove Leaf Oil
Clove Stem Oil
Cocoa Butter
Coconut Oil (Refined)
Coconut Oil (Unhydrogenated)

AHP

FCC

NF

X
X

X

USP

X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X

X
X
X

X
X
X
X
X

X
X
X
X
X
X
X
X
X

X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X

X

X
X
X
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Monograph
Coffee Fruit Dry Extract
Cognac Oil, Green
Coix Seed
Copaiba Oil
Coriander Oil
Costus Root Oil
Cramp Bark
Cranberry Fruit
Cranberry Liquid Preparation
Crypthecodinium cohnii Oil
Cubeb Oil
Cumin Oil
Curcuminoids
Dammar Gum
Dang Gui Root
Dill Seed Oil, European Type
Dill Seed Oil, Indian Type
Dillweed Oil, American Type
Echinacea angustifolia Root
Echinacea angustifolia Dry Extract
Echinacea pallida Root
Echinacea pallida Dry Extract
Echinacea purpurea Aerial Parts
Echinacea purpurea Dry Extract
Echinacea purpurea Root
Eleuthero Root and Rhizome
Eleuthero Root and Rhizome Dry Extract
Eucalyptus Oil
European Elder Berry Dry Extract
Evening Primrose Oil
Fennel Oil
Fenugreek Seed
Fenugreek Seed Dry Extract
Feverfew Aerial Parts
Feverfew Leaf
Fir Needle Oil, Canadian Type
Fir Needle Oil, Siberian Type
Flax Seed Oil
Forskohlii (Root)
Forskohlii Dry Extract
Galageenan
Ganoderma lucidum Fruiting Body
Garcinia cambogia (Pericarp)
Garcinia Hydroxycitrate Dry Extract
Garlic (Bulb)
Garlic Dry Extract
Garlic Fluidextract
Garlic Oil
Gellan Gum
Geranium Oil, Algerian Type
Ginger (Rhizome)
Ginger Oil
Ginger Tincture
Ginkgo Leaf

AHP

FCC

NF

USP
X

X
X
X
X
X

X

X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X

X
X
X

X

X
X
X

X

X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X

X
X
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X
X

Monograph
Ginkgo Leaf Dry Extract
Goldenseal (Root and Rhizome)
Goldenseal Dry Extract
Grape Seeds Oligomeric Proanthocyanidins
Grape Skin Extract
Grapefruit Oil, Cold-pressed
Green Tea Dry Extract, Decaffeinated
Guar Gum
Guggul (Oleo-gum-resin)
Guggul Native Extract
Guggul Purified Extract
Gum Ghatti
Gum Guaiac
Gymnema (Leaf)
Gymnema Native Extract
Gymnema Purified Extract
Hawthorn Berry
Hawthorn Leaf with Flower
Holy Basil Leaf
Holy Basil Leaf Dry Extract
Hops Oil
Horse Chestnut Seed
Horse Chestnut Seed Dry Extract
Japanese Honeysuckle Flower
Japanese Honeysuckle Flower Dry Extract
Juniper Berries Oil
Karaya Gum
Kelp
Konjac Flour
Labdanum Oil
Laurel Leaf Oil
Lavandin Oil, Abrial Type
Lavender Oil
Lemon Oil
Lemon Oil, Cold-pressed
Lemon Oil, Desert Type, Cold-pressed
Lemon Oil, Distilled
Lemon Tincture
Lemongrass Oil
Licorice (Root, Rhizome, Stolon)
Licorice Dry Extract
Licorice Fluidextract
Lime Oil, Cold-pressed
Lime Oil, Distilled
Linaloe Wood Oil
Locust (Carob) Bean Gum
Lovage Root Oil
Lutein
Lycium (goji) Berry
Lycopene
Lycopene Extract from Tomato
Lycopene from Blakeslea trispora
Lycopene Preparation
Mace Oil

AHP
X
X

FCC

NF

USP
X
X
X
X

X
X
X
X

X
X
X
X

X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
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Monograph
Malabar-Nut-Tree Leaf
Malabar-Nut-Tree Leaf Dry Extract
Mandarin Oil, Cold-pressed
Maritime Pine (Stem Bark)
Maritime Pine Extract
Marjoram Oil, Spanish Type
Marjoram Oil, Sweet
Masticatory Substances, Natural
Mentha arvensis Oil, Partially Dementholized
meso-Zeaxanthin
meso-Zeaxanthin Preparation
Milk Thistle (Ripe Fruit)
Milk Thistle Dry Extract
Monk Fruit Extract
Motherwort Aerial Parts
Mustard Oil
Myrrh (Oleo-Gum-Resin)
Myrrh Oil
Nutmeg Oil
Olibanum Oil
Olive Leaf
Olive Leaf Dry Extract
Onion Oil
Orange Oil
Orange Oil, Bitter, Cold-pressed
Orange Oil, Cold-pressed
Orange Oil, Distilled
Orange Peel Tincture, Sweet
Orange Spirit, Compound
Orange Syrup
Origanum Oil, Spanish Type
Orris Root Oil
Osha Root
Palm Kernel Oil
Palm Kernel Oil (Unhydrogenated)
Palm Oil, Hydrogenated
Palm Oil, Refined
Palm Oil (Unhydrogenated)
Palmarosa Oil
Papain
Parsley Herb Oil
Parsley Seed Oil
Pea Starch
Pectin
Pennyroyal Oil
Peppermint
Peppermint Oil
Peppermint Spirit
Peppermint Water
Petitgrain Oil, Paraguay Type
Phyllanthus amarus (Aerial Parts)
Pimenta Fruit Oil
Pimenta Leaf Oil
Pine Needle Oil, Dwarf

AHP

FCC

NF

USP
X
X

X
X
X

X
X
X
X
X
X

X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X

X
X

X
X
X
X

X
X
X
X
X
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Monograph
Pine Needle Oil, Scotch Type
Plant Stanol Esters
Plantago Seed
Psyllium Husk
Pygeum Bark
Pygeum Bark Extract
Rebaudioside A
Red Clover Aerial Parts
Red Clover Aerial Parts Isoflavone Aglycones Dry Extract
Red Clover Aerial Parts Dry Extract
Red Clover Flowering Tops, Aerial Parts, and Dry Extracts
Reishi Mushroom
Rhodiola crenulata Root and Rhizome
Rhodiola crenulata Root and Rhizome Dry Extract
Rhodiola rosea Root and Rhizome
Rhodiola rosea Root and Rhizome Dry Extract
Rhodiola rosea Root and Rhizome Tincture
Rose Oil
Rosemary Extract
Rosemary Leaf
Rosemary Leaf Dry Aqueous Extract
Rosemary Oil
Rose Water, Stronger
Rue Oil
Sage Oil, Dalmatian Type
Sage Oil, Spanish Type
Sandalwood Oil, East Indian Type
Salix Species Bark
Salix Species Bark Dry Extract
Savory Oil (Summer Type)
Saw Palmetto (Ripe Fruit)
Saw Palmetto Extract
Schisandra Berry
Schisandra Fruit, Northern
Schisandra Fruit, Northern, Dry Extract
Schizochytrium Oil
Senna Fluidextract
Senna Leaf
Senna Oral Solution
Senna Pods
Sennosides
Sheanut Oil, Refined
Skullcap Aerial Parts
Slippery Elm Inner Bark
Solin Oil
Soy Isoflavones Dry Extract
Spearmint Oil
Spice Oleoresins
Spike Lavender Oil
Spirulina
Star Anise Fruit
Steviol Glycosides
Stinging Nettle Herb
Stinging Nettle Root
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AHP

FCC
X
X

NF

USP
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X

X

X
X
X
X

X

Monograph
Stinging Nettle Root Dry Extract
St. John’s Wort Flowering Top
St. John's Wort Flowering Top Dry Extract
Storax (Balsam)
Tagetes Extract
Tangerine Oil, Cold-pressed
Tangerine Peel
Tangerine Peel Dry Extract
Tannic Acid (from nutgalls on Quercus tree twigs)
Tara Gum
Tarragon Oil
Tea Polyphenols from Green Tea, Decaffeinated
Thyme Oil
Tolu Balsam
Tolu Balsam Syrup
Tolu Balsam Tincture
Tapioca Starch
Tienchi Ginseng Root and Rhizome
Tienchi Ginseng Root and Rhizome Dry Extract
Tomato Extract Containing Lycopene
Tragacanth
Turmeric (Rhizome)
Turmeric Dry Extract
Turmeric Oleoresin
Uva Ursi Leaf
Valerian Root
Valerian Root Dry Extract
Valerian Root Tincture
Vanilla (Unripe Fruit)
Vanilla Tincture
Vegetable Oil Phytosterol Esters
Wheat Bran
Willow Bark
Wintergreen Oil

AHP

FCC

NF

X

USP
X
X
X
X

X
X
X
X
X

X
X
X
X
X

X
X
X
X
X
X
X
X

X
X
X

X
X
X

X
X
X
X
X
X
X

X
X
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